WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012051567) OBESITY-RELATED GENES AND THEIR PROTEINS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/051567    International Application No.:    PCT/US2011/056417
Publication Date: 19.04.2012 International Filing Date: 14.10.2011
IPC:
A61K 38/00 (2006.01), A61K 38/22 (2006.01), C07K 1/00 (2006.01), C12N 15/11 (2006.01), A61K 39/395 (2006.01)
Applicants: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK [US/US]; 412 Low Memorial Library 535 West 116th Street New York, NY 10027 (US) (For All Designated States Except US).
WALEWSKI, Jose, Leonardo [US/US]; (US) (For US Only).
BERK, Paul, David [US/US]; (US) (For US Only)
Inventors: WALEWSKI, Jose, Leonardo; (US).
BERK, Paul, David; (US)
Agent: LOVE, Jane, M.; Wilmer Cutler Pickering Hale and Door LLP 7 World Trade Center 250 Greenwich Street New York, NY 10007 (US)
Priority Data:
61/393,634 15.10.2010 US
Title (EN) OBESITY-RELATED GENES AND THEIR PROTEINS AND USES THEREOF
(FR) GÈNES DE L'OBÉSITÉ, LEURS PROTÉINES ET LEURS UTILISATIONS
Abstract: front page image
(EN)The disclosure provides methods for treating obesity or an obesity associated disorder in a subject. Specifically, the methods comprise administering to a subject an effective amount of Spexin, thereby treating obesity or an obesity-associated disorder in the subject. Further disclosed are obesity associated disorders that can be treated using the disclosed method, which include but not limited to a metabolic disorder, hypertension, congestive heart failure, a lipid related disorder, type II diabetes mellitus, gallbladder disease, osteoarthritis, atherosclerosis, sleep apnea, cancer, polycystic ovary syndrome (PCOS). Methods for determining an effective amount of Spexin for administration and measurement of effectiveness for the treatment are also disclosed.
(FR)La présente invention concerne des méthodes de traitement de l'obésité ou d'un trouble associé à l'obésité.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)